{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:30:57Z","timestamp":1792614657538,"version":"4.5.0"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100003161","name":"National Alopecia Areata Foundation","doi-asserted-by":"publisher","award":["67179251"],"award-info":[{"award-number":["67179251"]}],"id":[{"id":"10.13039\/100003161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012033","name":"Japanese Dermatological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jaut.2024.103217","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:42:52Z","timestamp":1712277772000},"page":"103217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Interleukin-15 is a hair follicle immune privilege guardian"],"prefix":"10.1016","volume":"145","author":[{"given":"Takahiro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Ch\u00e9ret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda D.","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rajabi-Estarabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysun","family":"Akhundlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana-Lee","family":"Demetrius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gherardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviad","family":"Keren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Harries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Rodriguez-Feliz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorana","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talveen","family":"Purba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Gilhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Paus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103217_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/bjd.20628","article-title":"The epidemiology of alopecia areata: a population-based cohort study in UK primary care","volume":"186","author":"Harries","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jaci.2019.08.035","article-title":"Frontiers in alopecia areata pathobiology research","volume":"144","author":"Gilhar","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103217_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2023.1261","article-title":"Autoimmune, inflammatory, Atopic, Thyroid, and Psychiatric Outcomes of Offspring Born to Mothers with alopecia areata","author":"Lee","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaut.2024.103217_bib5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/jid.2012.365","article-title":"Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata","volume":"133","author":"Gilhar","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.autrev.2016.03.008","article-title":"Alopecia areata: animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies","volume":"15","author":"Gilhar","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103217_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102711","article-title":"Resident human dermal \u03b3\u03b4T-cells operate as stress-sentinels: lessons from the hair follicle","volume":"124","author":"Uchida","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103217_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80768","article-title":"Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata","volume":"12","author":"Laufer Britva","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jaut.2024.103217_bib9","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jisp.2020.05.007","article-title":"Burden of Illness in alopecia areata: a cross-sectional online Survey study","volume":"20","author":"Mesinkovska","year":"2020","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.jaut.2024.103217_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s13555-021-00512-0","article-title":"Patient perspectives of the Social, Emotional and functional impact of alopecia areata: a systematic Literature review","volume":"11","author":"Mostaghimi","year":"2021","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jaut.2024.103217_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/bjd\/ljad054","article-title":"Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burden","volume":"189","author":"Gorbatenko-Roth","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/bjd.21055","article-title":"The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care","volume":"187","author":"Macbeth","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1203475418824079","article-title":"The Use of Janus kinase inhibitors in alopecia areata: a review of the Literature","volume":"23","author":"Crowley","year":"2019","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.jaut.2024.103217_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142205","article-title":"Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata","volume":"6","author":"Dai","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2024.103217_bib15","article-title":"The effect of JAK inhibitor on the survival, anagen Re-Entry, and hair follicle immune privilege restoration in human dermal papilla cells","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2024.103217_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.955035","article-title":"An overview of JAK\/STAT pathways and JAK inhibition in alopecia areata","volume":"13","author":"Lensing","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2020.03.004","article-title":"The Alopecia Areata Consensus of Experts (ACE) study: results of an international expert opinion on treatments for alopecia areata","volume":"83","author":"Meah","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(18)32987-8","article-title":"JAK inhibitors and alopecia areata","volume":"393","author":"Gilhar","year":"2019","journal-title":"Lancet Lond. Engl."},{"issue":"23","key":"10.1016\/j.jaut.2024.103217_bib19","article-title":"Factors predicting response to oral methylprednisolone tapering treatment in alopecia areata: a retrospective study","volume":"S0190\u20139622","author":"Han","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19121","article-title":"Real-data on the use of baricitinib in adolescents with severe alopecia areata","author":"Zhan","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"10.1016\/j.jaut.2024.103217_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.950450","article-title":"The efficacy and safety of JAK inhibitors for alopecia areata: a systematic review and meta-analysis of prospective studies","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jaut.2024.103217_bib22","first-page":"59","article-title":"Alopecia areata - current understanding and management","volume":"20","author":"Lintzeri","year":"2022","journal-title":"J. Dtsch. Dermatol. Ges. J. Ger. Soc. Dermatol. JDDG"},{"key":"10.1016\/j.jaut.2024.103217_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89776","article-title":"Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata","volume":"1","author":"Kennedy Crispin","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2024.103217_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2004.09.014","article-title":"A \u201chairy\u201d privilege","volume":"26","author":"Paus","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/exd.14155","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"29","author":"Bertolini","year":"2020","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","article-title":"Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model","volume":"164","author":"Ito","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2024.103217_bib27","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028449","article-title":"The common cytokine receptor \u03b3 chain family of cytokines","volume":"10","author":"Lin","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jaut.2024.103217_bib28","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41598-020-59798-3","article-title":"The anti-inflammatory potential of cefazolin as common gamma chain cytokine inhibitor","volume":"10","author":"\u017by\u017cy\u0144ska-Granica","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2024.103217_bib29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.abd.2021.03.006","article-title":"Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata","volume":"96","author":"A\u015fk\u0131n","year":"2021","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.5114\/ada.2020.102103","article-title":"Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity","volume":"37","author":"El Aziz Ragab","year":"2020","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.jaut.2024.103217_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/ijt.ijt_80_18","article-title":"Serum interleukin-15 is a marker of alopecia areata severity","volume":"11","author":"Ebrahim","year":"2019","journal-title":"Int. J. Trichology"},{"key":"10.1016\/j.jaut.2024.103217_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5114\/ada.2019.82826","article-title":"Serum concentrations of selected proinflammatory cytokines in children with alopecia areata","volume":"36","author":"Tabara","year":"2019","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.jaut.2024.103217_bib33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2024.103217_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5109772","article-title":"Interleukin-15 and Tumor Necrosis factor-\u03b1 in Iraqi patients with alopecia areata","volume":"2023","author":"Kamil","year":"2023","journal-title":"Dermatol. Res. Pract."},{"key":"10.1016\/j.jaut.2024.103217_bib35","first-page":"33","article-title":"Interferon-gamma in alopecia areata","volume":"14","author":"Arca","year":"2004","journal-title":"Eur. J. Dermatol. EJD"},{"key":"10.1016\/j.jaut.2024.103217_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2133.2006.07377.x","article-title":"Interferon-gamma-deficient mice are resistant to the development of alopecia areata","volume":"155","author":"Freyschmidt-Paul","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/exd.12209","article-title":"What causes alopecia areata?","volume":"22","author":"McElwee","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib38","article-title":"Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCR\u03b2-chain, which highlights the immunopathological aspect of the disease","volume":"14","author":"Hamed","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2024.103217_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4103\/ijdvl.IJDVL_738_17","article-title":"A cross-sectional study of the histopathology and immunology of alopecia areata: Unearthing the role of the Janus kinase-signal transducer and activator of transcription pathway","volume":"85","author":"Bansal","year":"2019","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.jaut.2024.103217_bib40","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jisp.2017.10.014","article-title":"Hair follicle immune privilege Revisited: the key to alopecia areata management","volume":"19","author":"Paus","year":"2018","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.jaut.2024.103217_bib41","doi-asserted-by":"crossref","first-page":"pgac297","DOI":"10.1093\/pnasnexus\/pgac297","article-title":"Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata","volume":"2","author":"Tsai","year":"2023","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.jaut.2024.103217_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103061","article-title":"The current state of knowledge of the immune ecosystem in alopecia areata","volume":"21","author":"Connell","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103217_bib43","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2133.2005.06453.x","article-title":"Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles","volume":"152","author":"Ito","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.11","article-title":"Alopecia areata","volume":"3","author":"Pratt","year":"2017","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.jaut.2024.103217_bib45","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/bjd.16808","article-title":"Alopecia areata: a review of disease pathogenesis","volume":"179","author":"Rajabi","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/intimm\/dxz039","article-title":"Pathomechanisms of immune-mediated alopecia","author":"Anzai","year":"2019","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155258","article-title":"Interleukin-15 in autoimmunity","volume":"136","author":"Allard-Chamard","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2024.103217_bib49","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.it.2022.08.004","article-title":"Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib50","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.3390\/ijms23137311","article-title":"Interleukin 15 in cell-based cancer immunotherapy","volume":"23","author":"Zhou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2024.103217_bib51","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","article-title":"Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack","volume":"128","author":"Ito","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2024.103217_bib53","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/eji.200535290","article-title":"Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells","volume":"36","author":"Rausch","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib54","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121949","article-title":"High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata","volume":"3","author":"de Jong","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2024.103217_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12730","article-title":"NK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activation","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2024.103217_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2016.10.004","article-title":"IL-15 signaling in NK cell cancer immunotherapy","volume":"44","author":"Rautela","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib57","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1172\/JCI90387","article-title":"CD56bright NK cells exhibit potent antitumor responses following IL-15 priming","volume":"127","author":"Wagner","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2024.103217_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17442-7","article-title":"Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse","volume":"7","author":"Katano","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2024.103217_bib59","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41590-023-01547-5","article-title":"A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity","volume":"24","author":"Seok","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib60","first-page":"297","article-title":"Different dynamics of IL-15R activation following IL-15 cis- or trans-presentation","volume":"21","author":"Perdreau","year":"2010","journal-title":"Eur. Cytokine Netw."},{"issue":"90","key":"10.1016\/j.jaut.2024.103217_bib61","article-title":"Association between immunity and different clinical symptoms in patients with polycystic ovary syndrome","volume":"1989","author":"Xiao","year":"2023","journal-title":"Am. J. Reprod. Immunol. N. Y. N"},{"key":"10.1016\/j.jaut.2024.103217_bib62","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1038\/s41598-020-62654-z","article-title":"Phenotypic and functional characterization of natural killer cells in rheumatoid arthritis-regulation with interleukin-15","volume":"10","author":"Lin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2024.103217_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1432","article-title":"A peptoid interleukin-15 receptor antagonist suppresses inflammation and arthritis in mice","volume":"11","author":"Cho","year":"2022","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/jir.2022.0198","article-title":"Counteracting interleukin-15 to Elucidate its modes of action in physiology and Pathology, J. Interferon cytokine Res. Off","volume":"43","author":"Mortier","year":"2023","journal-title":"J. Int. Soc. Interferon Cytokine Res."},{"key":"10.1016\/j.jaut.2024.103217_bib65","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.12191","article-title":"IL-15: a central regulator of celiac disease immunopathology","volume":"260","author":"Abadie","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2024.103217_bib66","first-page":"9","article-title":"Immune modulation of hair follicle regeneration, NPJ Regen","volume":"5","author":"Rahmani","year":"2020","journal-title":"Med."},{"key":"10.1016\/j.jaut.2024.103217_bib67","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/ni.2353","article-title":"Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin","volume":"13","author":"Nagao","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib68","article-title":"Exploring the human hair follicle microbiome","author":"Lousada","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib69","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","article-title":"The \u03b3c family of cytokines: Basic biology to therapeutic Ramifications","volume":"50","author":"Leonard","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2024.103217_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/jidsymp.2013.8","article-title":"The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders","volume":"16","author":"Waldmann","year":"2013","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.jaut.2024.103217_bib71","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103217_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2023.06.206","article-title":"IL-15 prolongs anagen, stimulates proliferation, and suppresses apoptosis in the hair matrix of human scalp hair follicles","volume":"144","author":"Suzuki","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2017.08.002","article-title":"Immunobiology of the IL-15\/IL-15R\u03b1 complex as an antitumor and antiviral agent","volume":"38","author":"Guo","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jaut.2024.103217_bib74","series-title":"Means for Stimulation and Activation of Hair Growth by Il-15, WO2005063279A1","author":"Beissert","year":"2005"},{"key":"10.1016\/j.jaut.2024.103217_bib75","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm1097-1124","article-title":"Interleukin-15 protects from lethal apoptosis in vivo","volume":"3","author":"Bulfone-Paus","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2024.103217_bib76","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/eji.201344238","article-title":"IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK\/STAT and PI3K\/AKT pathways in T cells","volume":"44","author":"Shenoy","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib77","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.molimm.2008.01.001","article-title":"Bcl-xL is associated with the anti-apoptotic effect of IL-15 on the survival of CD56(dim) natural killer cells","volume":"45","author":"Zheng","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib78","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1523-1747.1998.00141.x","article-title":"Inhibition of chemotherapy-induced keratinocyte apoptosis in vivo by an interleukin-15-IgG fusion protein","volume":"110","author":"Lindner","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib79","unstructured":"Cefazolin and Hair loss, a phase IV clinical study of FDA data - eHealthMe, (n.d.). https:\/\/www.ehealthme.com\/ds\/cefazolin\/hair-loss\/(accessed August 10, 2023)."},{"key":"10.1016\/j.jaut.2024.103217_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/srep36962","article-title":"Soluble \u03b3c cytokine receptor suppresses IL-15 signaling and impairs iNKT cell development in the thymus","volume":"6","author":"Park","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2024.103217_bib81","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1038\/s41467-018-05097-5","article-title":"TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2024.103217_bib82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaut.2018.04.001","article-title":"iNKT cells ameliorate human autoimmunity: lessons from alopecia areata","volume":"91","author":"Ghraieb","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103217_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2002864","article-title":"Autophagy is essential for maintaining the growth of a human (mini-)organ: evidence from scalp hair follicle organ culture","volume":"16","author":"Parodi","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jaut.2024.103217_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2020.08.006","article-title":"Does dysfunctional autophagy contribute to immune privilege collapse and alopecia areata pathogenesis?","author":"Hardman","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jaut.2024.103217_bib85","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/bjd.14645","article-title":"Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse","volume":"175","author":"Bertolini","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib86","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jisp.2020.05.001","article-title":"Mouse models of alopecia areata: C3H\/HeJ mice versus the humanized AA mouse model","volume":"20","author":"Gilhar","year":"2020","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.jaut.2024.103217_bib87","article-title":"Pro-inflammatory V\u03b41+T-cells infiltrates are present in and around the hair bulbs of non-lesional and lesional alopecia areata hair follicles","volume":"0","author":"Uchida","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jaut.2024.103217_bib88","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/exd.12836","article-title":"Human hair follicle organ culture: theory, application and perspectives","volume":"24","author":"Langan","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115963","article-title":"Melatonin exerts prominent, differential epidermal and dermal anti-Aging properties in aged human eyelid skin ex vivo","volume":"24","author":"Samra","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2024.103217_bib90","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14740","article-title":"Concentration-dependent stimulation of melanin production as well as melanocyte and keratinocyte proliferation by melatonin in human eyelid epidermis","author":"Sevilla","year":"2023","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227817","article-title":"Tissue-resident macrophages can be generated de novo in adult human skin from resident progenitor cells during substance P-mediated neurogenic inflammation ex vivo","volume":"15","author":"Gherardini","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2024.103217_bib92","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.ai.2022.09.002","article-title":"The implications of IL-15 trans-presentation on the immune response","volume":"156","author":"Waldmann","year":"2022","journal-title":"Adv. Immunol."},{"issue":"2024","key":"10.1016\/j.jaut.2024.103217_bib93","first-page":"992","article-title":"IL-15 complex-induced IL-10 enhances Plasmodium-specific CD4+ T follicular helper differentiation and antibody production","volume":"212","author":"Bravo","year":"1950","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.jaut.2024.103217_bib94","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12681","article-title":"Common gamma chain cytokines promote regulatory T cell development and survival at the CD4+ CD8+ stage in the human thymus","author":"Vanhanen","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib95","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/exd.14129","article-title":"Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata","volume":"29","author":"Ito","year":"2020","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib96","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.12.003","article-title":"CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase","volume":"69","author":"Ito","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jaut.2024.103217_bib97","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1046\/j.1365-2133.2000.03464.x","article-title":"The human hair follicle immune system: cellular composition and immune privilege","volume":"142","author":"Christoph","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib98","first-page":"1077","article-title":"Evidence that the bulge region is a site of relative immune privilege in human hair follicles","volume":"159","author":"Meyer","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib99","first-page":"1332","article-title":"Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol","volume":"19","author":"Ito","year":"2005","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.jaut.2024.103217_bib100","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/en.2004-1145","article-title":"A fully functional proopiomelanocortin\/melanocortin-1 receptor system regulates the differentiation of human scalp hair follicle melanocytes","volume":"146","author":"Kauser","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2024.103217_bib101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1523-1747.1998.00228.x","article-title":"MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo","volume":"111","author":"R\u00fcckert","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib102","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1523-1747.2002.01746.x","article-title":"Involvement of transforming growth factor-beta2 in catagen induction during the human hair cycle","volume":"118","author":"Soma","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib103","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.0022-202X.2005.23686.x","article-title":"Towards dissecting the pathogenesis of retinoid-induced hair loss: all-trans retinoic acid induces premature hair follicle regression (catagen) by upregulation of transforming growth factor-beta2 in the dermal papilla","volume":"124","author":"Foitzik","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib104","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1210\/jc.2008-0283","article-title":"Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation","volume":"93","author":"van Beek","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2024.103217_bib105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jid.2015.12.003","article-title":"Laser Capture microdissection reveals Transcriptional abnormalities in alopecia areata before, during, and after active hair loss","volume":"136","author":"Li","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib106","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0625.2011.01432.x","article-title":"Calcitonin gene-related peptide (CGRP) may award relative protection from interferon-\u03b3-induced collapse of human hair follicle immune privilege","volume":"21","author":"Kinori","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1183668","article-title":"The roles of different forms of IL-15 in human melanoma progression","volume":"14","author":"Di Matteo","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886213","article-title":"Selective targeting of IL-15R\u03b1 is sufficient to reduce inflammation","volume":"13","author":"Meghnem","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib109","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202256574","article-title":"mTORC1 activity negatively regulates human hair follicle growth and pigmentation","author":"Suzuki","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jaut.2024.103217_bib110","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/jid.2013.366","article-title":"A meeting of two chronobiological systems: circadian proteins Period1 and BMAL1 modulate the human hair cycle clock","volume":"134","author":"Al-Nuaimi","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib111","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1038\/s41467-018-05973-0","article-title":"Olfactory receptor OR2AT4 regulates human hair growth","volume":"9","author":"Ch\u00e9ret","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2024.103217_bib112","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/jid.2014.442","article-title":"The peripheral clock regulates human pigmentation","volume":"135","author":"Hardman","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib113","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.jid.2021.02.747","article-title":"Hair follicle Chemosensation: TRPM5 signaling is required for anagen maintenance","volume":"141","author":"Mardaryev","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib114","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/jid.2012.171","article-title":"P-cadherin regulates human hair growth and cycling via canonical Wnt signaling and transforming growth factor-\u03b22","volume":"132","author":"Samuelov","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"21","key":"10.1016\/j.jaut.2024.103217_bib115","first-page":"S0022","article-title":"UDP-GlcNAc-1-Phosphotransferase is a clinically important regulator of human and mouse hair pigmentation","author":"Tiede","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib116","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4103\/idoj.idoj_452_22","article-title":"Which is the ideal JAK inhibitor for alopecia areata - baricitinib, tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK pathway","volume":"14","author":"Sardana","year":"2023","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.jaut.2024.103217_bib117","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2242706","article-title":"Successful treatment of alopecia universalis with abrocitinib: a case report","volume":"34","author":"Zhang","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jaut.2024.103217_bib118","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-023-01873-w","article-title":"Baricitinib for the treatment of alopecia areata","volume":"83","author":"Freitas","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jaut.2024.103217_bib119","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdermsci.2014.11.009","article-title":"The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo","volume":"77","author":"Keren","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jaut.2024.103217_bib120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cyto.2015.09.015","article-title":"Interleukin-15 enhances the expansion and function of natural killer T cells from adult peripheral and umbilical cord blood","volume":"76","author":"Lin","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2024.103217_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261727","article-title":"Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15","volume":"16","author":"Hsu","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2024.103217_bib122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-0716-1775-5_11","article-title":"Expansion of human iNKT cells ex vivo","volume":"2388","author":"Wang","year":"2021","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"10.1016\/j.jaut.2024.103217_bib123","article-title":"Transcription factors associated with IL-15 cytokine signaling during NK cell development","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2021.103658","article-title":"Interleukin-15 modulates the response of cortical neurons to ischemia","volume":"115","author":"Nguyen","year":"2021","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jaut.2024.103217_bib125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fimmu.2018.00523","article-title":"Astrocytic interleukin-15 reduces Pathology of Neuromyelitis Optica in mice","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib126","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","article-title":"CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells","volume":"12","author":"Koda","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2024.103217_bib127","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2305764120","article-title":"Functional interrogation of lymphocyte subsets in alopecia areata using single-cell RNA sequencing","volume":"120","author":"Lee","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2024.103217_bib128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12865-022-00486-4","article-title":"CD4, CD8 and natural killer cells are depressed in patients with alopecia areata: their association with disease activity","volume":"23","author":"Younes","year":"2022","journal-title":"BMC Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2020.08.015","article-title":"Low-dose IL-2 for treating Moderate to severe alopecia areata: a 52-week Multicenter prospective Placebo-controlled study assessing its impact on T regulatory cell and NK cell populations","volume":"141","author":"Le Duff","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12979-022-00305-9","article-title":"Excessive IL-15 promotes cytotoxic CD4 + CD28- T cell-mediated renal injury in lupus nephritis","volume":"19","author":"Zhang","year":"2022","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.jaut.2024.103217_bib131","article-title":"Coordinated priming of NKG2D pathway by IL-15 Enhanced functional properties of cytotoxic CD4+CD28- T cells expanded in systemic lupus erythematosus","author":"Wang","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.jaut.2024.103217_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1117092","article-title":"IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib133","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000494613","article-title":"Janus kinase inhibitors for the treatment of severe alopecia areata: an Open-Label Comparative study","volume":"235","author":"Almutairi","year":"2019","journal-title":"Dermatol. Basel Switz."},{"key":"10.1016\/j.jaut.2024.103217_bib134","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jid.2018.01.032","article-title":"An Open-Label pilot study to evaluate the efficacy of tofacitinib in Moderate to severe Patch-Type alopecia areata, Totalis, and universalis","volume":"138","author":"Jabbari","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib135","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-023-00746-x","article-title":"Strategies to therapeutically modulate cytokine action","volume":"22","author":"Leonard","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2024.103217_bib136","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/1744666X.2022.2042254","article-title":"Affecting the effectors: JAK inhibitors modulation of immune cell numbers and functions in patients with rheumatoid arthritis","volume":"18","author":"Garufi","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib137","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.7150\/thno.47860","article-title":"Tofacitinib restores the balance of \u03b3\u03b4Treg\/\u03b3\u03b4T17 cells in rheumatoid arthritis by inhibiting the NLRP3 inflammasome","volume":"11","author":"Yang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jaut.2024.103217_bib138","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/mi.2017.38","article-title":"Jak3 deficiency blocks innate lymphoid cell development","volume":"11","author":"Robinette","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib139","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000254503","article-title":"A new classification of alopecia areata","volume":"131","author":"Ikeda","year":"1965","journal-title":"Dermatol."},{"key":"10.1016\/j.jaut.2024.103217_bib140","doi-asserted-by":"crossref","first-page":"c3671","DOI":"10.1136\/bmj.c3671","article-title":"Management of alopecia areata","volume":"341","author":"Harries","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jaut.2024.103217_bib141","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12016-017-8620-9","article-title":"Alopecia areata: a Comprehensive review of pathogenesis and management","volume":"54","author":"Tr\u00fceb","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2024.103217_bib142","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jdv.19665","article-title":"Long-term efficacy and safety of baricitinib in patients with severe alopecia areata: 104-week results from BRAVE-AA1 and BRAVE-AA2","volume":"38","author":"Senna","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"10.1016\/j.jaut.2024.103217_bib143","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19797","article-title":"Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: a systematic review and Bayesian network meta-analysis","author":"Husein-ElAhmed","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"10.1016\/j.jaut.2024.103217_bib144","doi-asserted-by":"crossref","first-page":"adv12425","DOI":"10.2340\/actadv.v103.12425","article-title":"Effectiveness and Predictive factors of response to tofacitinib therapy in 125 patients with alopecia areata: a single-centre Real-world retrospective study","volume":"103","author":"Huang","year":"2023","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jaut.2024.103217_bib145","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jaad.2023.05.049","article-title":"Janus kinase inhibitors for alopecia areata","volume":"89","author":"King","year":"2023","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:06:50Z","timestamp":1715958410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":145,"alternative-id":["S0896841124000519"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103217","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-15 is a hair follicle immune privilege guardian","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103217"}}